Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Deglycosylated Azithromycin Attenuates Bleomycin-Induced Pulmonary Fibrosis via the TGF-β1 Signaling Pathway.

Molecules (Basel, Switzerland) - 10 May 2021

Ruan Hao, Gao Shaoyan, Li Shuangling, Luan Jiaoyan, Jiang Qiuyan, Li Xiaohe, Yin Huijun, Zhou Honggang, Yang Cheng

Abstract excerpt

Idiopathic pulmonary fibrosis (IPF) is a progressive, life-threatening lung disease characterized by the proliferation of myofibroblasts and deposition of extracellular matrix that results in irreversible distortion of the lung structure and the formation of focal fibrosis. The molecular mechanism of IPF is not fully understood, and there is no satisfactory treatment. However, most studies suggest that abnormal...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Azithromycin
Share to Bleomycin

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Epithelial-Mesenchymal Transition

Share to Glycosylation

Share to Idiopathic Pulmonary Fibrosis

Share to Myofibroblasts

Share to NIH 3T3 Cells

Share to Transforming Growth Factor beta1

Source

Open in PubMed Open full text

Identifiers

PMID: 34068694
DOI: 10.3390/molecules26092820
PMCID: PMC8126120

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Deglycosylated Azithromycin Attenuates Bleomycin-Induced Pulmonary Fibrosis via the TGF-β1 Signaling Pathway.PMID 34068694Read ↗

EM703 improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of TGF-β signaling in lung fibroblastsSemantic proximity Read ↗

Nifuroxazide Ameliorates Pulmonary Fibrosis By Blocking Myofibroblast Genesis And Stat3 Activation: A Drug Repurposing StudySemantic proximity Read ↗

Codonopsis radix improves bleomycin-induced idiopathic pulmonary fibrosis by regulating TGF-β1/Smad signaling pathway and inhibiting fibroblast differentiation and proliferationSemantic proximity Read ↗

Azithromycin Treatment Alters Gene Expression in Inflammatory, Lipid Metabolism, and Cell Cycle Pathways in Well-Differentiated Human Airway EpitheliaSemantic proximity Read ↗

The mechanism of Qingwen Gupi decoction on pulmonary fibrosis based on metabolomics and intestinal floraSemantic proximity Read ↗

Combined transcriptomic and proteomic analysis reveals the mechanism of Xing-Qi-Huo-Xue granules on BLM-induced pulmonary fibrosis in ratsSemantic proximity Read ↗

Kasugamycin is a novel chitinase 1 inhibitor with strong antifibrotic effects on pulmonary fibrosisSemantic proximity Read ↗

Long-Term Macrolides in Chronic Respiratory Diseases: Dusk or a New Dawn? A Narrative ReviewSemantic proximity Read ↗

Azithromycin alters spatial and temporal dynamics of airway microbiota in idiopathic pulmonary fibrosisSemantic proximity Read ↗

Curdione ameliorates bleomycin-induced pulmonary fibrosis by repressing TGF-β-induced fibroblast to myofibroblast differentiationSemantic proximity Read ↗

Azithromycin Downregulates Gene Expression of IL-1β and Pathways Involving TMPRSS2 and TMPRSS11D Required by SARS-CoV-2Semantic proximity Read ↗

Baricitinib improves the efficacy of nintedanib for the treatment of idiopathic pulmonary fibrosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.